Pediatric Tumors Immunological and Molecular Markers

Description

This monograph explains the considerable impact that monoclonal antibodies and molecular probes have had on the diagnosis of tumor types and sub-types. It explains how radiolabelled monoclonal antibodies have also been used as imaging agents to try to improve the oncologist's ability to define residual tumor deposits after combination chemo/radiotherapy. Finally the childhood malignancies that still have a poor prognosis are presented and new novel ways of therapy are explained. | Pediatric Tumors Immunological and Molecular Markers